Consonance Capital Partners (CCP) recently announced it closed its third flagship fund at the hard cap of $1.35 billion.
The firm indicated that the new fund, Consonance Private Equity III, will focus on investments in U.S. healthcare companies in the lower and middle markets, consistent with its previous funds.
CCP, founded in 2005 and based in New York, pursues investments, including growth equity, leveraged buyouts and recapitalization transactions, in U.S. middle market companies exclusively in the healthcare industry. The firm targets companies that generally have between $25 million and $500 million in revenue.